Access & Prescribing (Australia & Global)
US Regulatory Landscape Evolves with Dual Pathways for Psychedelic Medicine Access
The US is developing dual regulatory pathways for psychedelic medicine access, combining pharmaceutical approvals with community-based models. Understand…
Global Regulatory Updates
Ohio Cannabis Referendum Campaign Faces Allegations of Unpaid Signature Collectors
Petitioners for the Ohio cannabis referendum campaign allege they were not fully compensated for signature collection efforts. Learn about the payment dis…
Access & Prescribing (Australia & Global)
US Hemp Ban Threatens CBD Market and Medicare Reimbursement Pilot Program
A looming US hemp ban, set for November 2026, could criminalize most CBD products and derail a Medicare pilot program. Understand the regulatory shift and…
Equities, Investment & Market Trends
Canada Dominates German Medical Cannabis Imports in Q1 2026, Supplying Over Half of 50,539 kg Total
Germany's Q1 2026 medical cannabis imports hit 50,539 kg, with Canada providing over half. Explore supplier dynamics, EU-GMP rules, and Germany's evolving…
Access & Prescribing (Australia & Global)
The Imperative for Clear and Actionable Medicinal Cannabis Guidelines
Vague guidelines hinder patient care. Clear, actionable medicinal cannabis guidelines are crucial for clinicians and patients to navigate treatment safely…
Australian Cannabis Policy & Law
ATF Proposes Form Changes Amid Supreme Court Review, Signalling Potential Shift in Medical Cannabis Patient Gun Ownership Rights
Federal law prohibiting medical cannabis patients from owning firearms may change. Learn about proposed ATF Form 4473 revisions, a pending Supreme Court c…
Equities, Investment & Market Trends
Medical Cannabis Company Atlantic Medicinal Partners Closes Amidst US$6.11 Million in Lawsuits
Atlantic Medicinal Partners, a medical cannabis company, has ceased operations in Massachusetts, facing two lawsuits seeking US$6.11 million for alleged u…
Australian Cannabis Policy & Law
DEA Clarifies Intent of ‘Red-Flag’ Question on Medical Cannabis Schedule III Registration Application
The DEA has clarified its 'red-flag' question on the medical cannabis Schedule III registration application, stating it's not a barrier to entry. Understa…
Equities, Investment & Market Trends
Texas Smokable Hemp Ban Faces Ongoing Legal Volatility, Creating Industry Uncertainty
The Texas smokable hemp ban continues to create significant legal and operational uncertainty for businesses. Learn about the court battles, economic impa…
Cannabinoid Pharmacology
UC San Diego Research Explores Impact of Adolescent Cannabis Use on Cognitive Development
New UC San Diego research from the large Adolescent Brain Cognitive Development Study suggests adolescent cannabis use may be associated with slower cogni…
